Beijing Sun-Novo Pharmaceutical Research Co., Ltd.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.verified

688621.SS

Price:

$64.52

Market Cap:

$7.05B

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokineti...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2021-06-21

Stock Exchange

SHH

Ticker

688621.SS

The Enterprise Value as of December 2025 (TTM) for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) is 7.07B

According to Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.07B. This represents a change of 31.11% compared to the average of 5.39B of the last 4 quarters.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Historical Enterprise Value (quarterly & annually)

How has 688621.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. over the last ten years is 7.32B. The current 7.07B Enterprise Value has changed 9.55% with respect to the historical average. Over the past ten years (40 quarters), 688621.SS's Enterprise Value was at its highest in in the March 2023 quarter at 8.74B. The Enterprise Value was at its lowest in in the March 2020 quarter at -69332359.48.

Quarterly (TTM)
Annual

Average

7.32B

Median

7.69B

Minimum

4.08B

Maximum

9.55B

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 85.37%

Maximum Annual Enterprise Value = 9.55B

Minimum Annual Increase = -46.63%

Minimum Annual Enterprise Value = 4.08B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20244.08B-45.93%
20237.54B-3.78%
20227.84B-16.99%
20219.44B85.37%
20205.10B-46.63%
20199.55B34.81%
20187.08B-10.89%

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Average Enterprise Value

How has 688621.SS Enterprise Value performed in the past?

The current Enterprise Value of Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

6.49B

5-year avg

6.80B

10-year avg

7.32B

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) Enterprise Value vs. Peers

How is 688621.SS’s Enterprise Value compared to its peers?

Beijing Sun-Novo Pharmaceutical Research Co., Ltd.’s Enterprise Value is greater than Zhejiang Yatai Pharmaceutical Co., Ltd. (4.64B), greater than Jinghua Pharmaceutical Group Co., Ltd. (5.33B), greater than Shenzhen Weiguang Biological Products Co., Ltd. (6.43B), greater than Shanghai Kaibao Pharmaceutical CO.,Ltd (5.59B), greater than ChengDu ShengNuo Biotec Co.,Ltd. (6.70B), greater than Jianmin Pharmaceutical Group Co.,Ltd. (5.56B), greater than Jiangsu Jibeier Pharmaceutical Co., Ltd. (5.02B), greater than Hunan Warrant Pharmaceutical Co.,Ltd (6.37B), greater than Beijing Science Sun Pharmaceutical Co., Ltd. (5.08B), less than Shenzhen Neptunus Bioengineering Co., Ltd. (20.93B),

Build a custom stock screener for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Beijing Sun-Novo Pharmaceutical Research Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Beijing Sun-Novo Pharmaceutical Research Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Beijing Sun-Novo Pharmaceutical Research Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)?

What is the 3-year average Enterprise Value for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)?

What is the 5-year average Enterprise Value for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS)?

How does the current Enterprise Value for Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) compare to its historical average?